0001209191-19-024303.txt : 20190410
0001209191-19-024303.hdr.sgml : 20190410
20190410175222
ACCESSION NUMBER: 0001209191-19-024303
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190407
FILED AS OF DATE: 20190410
DATE AS OF CHANGE: 20190410
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LASEZKAY GEORGE M
CENTRAL INDEX KEY: 0001020514
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37783
FILM NUMBER: 19742447
MAIL ADDRESS:
STREET 1: 1301 SECOND AVE., SUITE 4200
CITY: SEATTLE
STATE: WA
ZIP: 98101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clearside Biomedical, Inc.
CENTRAL INDEX KEY: 0001539029
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 452437375
STATE OF INCORPORATION: GA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 NORTH POINT PARKWAY
STREET 2: SUITE 200
CITY: ALPHARETTA
STATE: 2Q
ZIP: 30005
BUSINESS PHONE: 678-270-3631
MAIL ADDRESS:
STREET 1: 900 NORTH POINT PARKWAY
STREET 2: SUITE 200
CITY: ALPHARETTA
STATE: 2Q
ZIP: 30005
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-04-07
0
0001539029
Clearside Biomedical, Inc.
CLSD
0001020514
LASEZKAY GEORGE M
C/O CLEARSIDE BIOMEDICAL, INC.
900 NORTH POINT PARKWAY, SUITE 200
ALPHARETTA
GA
30005
1
1
0
0
Interim CEO
Stock Option (right to buy)
1.40
2019-04-07
4
A
0
250000
0.00
A
2029-04-06
Common Stock
250000
250000
D
The shares underlying this option vest in six equal monthly installments beginning on May 7, 2019.
/s/ Mark Ballantyne, Attorney-in-Fact
2019-04-10